Sirius Medical Expands Surgical Marker Navigation in the U.S.

2023-09-07
EINDHOVEN, NL, Sept. 7, 2023 /PRNewswire/ -- Sirius Medical, a leader in value-based healthcare and surgical marker navigation announced that LifeBridge Health, with locations across Maryland, will offer tumor localization with the Pintuition® surgical marker navigation system.
Continue Reading
Sirius Medical Expands Surgical Marker Navigation in the U.S.
Preview
来源: PRNewswire
Sirius Medical Expands in the U.S.
With many breast cancers being diagnosed at an early stage, the tumor often cannot be seen during surgery.  Pintuition is a next generation technology that is rapidly changing how tumors are localized.  The system use GPSDetect™ software providing unmatched directional guidance to locate tumors easily and accurately.  Patients benefit from enhanced diagnostic accuracy, reduced procedure times, and improved treatment planning.
"We are always searching for ways to create a better experience for our patients, adding new technology with surgical marker navigation to our breast cancer program further enhances our patient-centered care," says Dona Hobart, M.D., LifeBridge Health Medical Group.
"We are pleased to welcome LifeBridge Health to our expanding customer base in the U.S.," states Bram Schermers, CEO, Sirius Medical. "Physicians and administrators are embracing surgical marker navigation validating its simplicity, precision, and affordability."
For more information about Sirius Medical please visit www.sirius-medical.com
With its roots deeply embedded in the Netherlands Cancer InstituteCancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The Pintuition technology is precise, simple, affordable and both CE marked, and FDA cleared. Sirius Medical is rapidly expanding with over 14,000 procedures worldwide in over 175 centers combined with a global commercial network covering the USA, Western Europe and Australia-New Zealand.
Media Contact:
Benjamin Tchang - Corporate contact
[email protected]
+31 857 732 727 (The Netherlands)
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。